Stockscreener 앱 받기
166.56
0.58%
-0.97
시간 외 거래:
166.56
전일 마감가:
$167.53
열려 있는:
$167.44
하루 거래량:
880.35K
Relative Volume:
0.66
시가총액:
$22.86B
수익:
$1.96B
순이익/손실:
$-253.24M
주가수익비율:
-87.20
EPS:
-1.91
순현금흐름:
$94.06M
1주 성능:
-0.79%
1개월 성능:
+21.96%
6개월 성능:
+17.01%
1년 성능:
+47.09%
1일 변동 폭
$166.12
$168.56
1주일 범위
$164.48
$170.72
52주 변동 폭
$110.57
$183.00
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
NTRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
166.56 | 23.24B | 1.96B | -253.24M | 94.06M | -1.91 |
|
TMO
Thermo Fisher Scientific Inc
|
489.49 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.03 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.44 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.48 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
184.08 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Natera Introduces Prenatal Test for Inherited Conditions - Medical Product Outsourcing
Published on: 2025-09-03 12:36:09 - Newser
Statistical indicators supporting Natera Inc.’s strengthJuly 2025 Trends & Safe Capital Growth Plans - Newser
Real time breakdown of Natera Inc. stock performanceIndex Update & High Conviction Buy Zone Alerts - Newser
Natera Inc. stock retracement – recovery analysisJuly 2025 PostEarnings & Community Verified Trade Signals - Newser
What Natera (NTRA)'s AI-Driven Clinical Trial Integration Means For Shareholders - simplywall.st
RBC Raises Price Target on Natera to $268 From $255, Keeps Outperform Rating - MarketScreener
Can swing trading help recover from Natera Inc. losses2025 Sector Review & Weekly High Conviction Ideas - Newser
Is Natera Inc. stock reversal real or fake2025 Top Gainers & High Win Rate Trade Tips - Newser
Detecting price anomalies in Natera Inc. with AIJuly 2025 Summary & Real-Time Stock Price Movement Reports - Newser
Is Natera Inc. forming a bottoming baseQuarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser
Is a relief rally coming for Natera Inc. holders2025 Sector Review & Stock Portfolio Risk Control - Newser
Real time pattern detection on Natera Inc. stockStock Surge & AI Forecasted Entry/Exit Points - Newser
Should you wait for a breakout in Natera Inc.2025 Analyst Calls & Free Community Supported Trade Ideas - Newser
Risk vs reward if holding onto Natera Inc.Earnings Overview Report & Low Drawdown Trading Techniques - Newser
Tick level data insight on Natera Inc. volatilityQuarterly Trade Report & Daily Oversold Stock Bounce Ideas - Newser
Will Natera Inc. rebound enough to break evenMarket Sentiment Summary & Reliable Entry Point Alerts - Newser
Aug Volume: Can Natera Inc. disrupt its industryJuly 2025 Short Interest & Safe Entry Point Alerts - khodrobank.com
Natera director Chapman sells $459k in shares - Investing.com
Natera price target raised to $268 from $255 at RBC Capital - TipRanks
Is Natera Inc. in a bullish channel2025 Key Lessons & Risk Controlled Daily Trade Plans - khodrobank.com
What’s the outlook for Natera Inc.’s sectorTrade Risk Assessment & Fast Entry Momentum Alerts - khodrobank.com
Natera: A Strategic Growth Play with Cash Flow Resilience in a High-Growth Genomic Testing Market - AInvest
Natera: A Compelling Buy Due to Strong Growth and Cash Flow - AInvest
Natera: A Buy As Positive Growth And Cashflow Outweigh Unprofitability - Seeking Alpha
How to interpret RSI for Natera Inc. stockJuly 2025 Catalysts & Fast Gaining Stock Strategy Reports - Newser
MoFo helps NeoGenomics secure cancer test kit patent infringement win against rival Natera - The Global Legal Post
Applying Wyckoff theory to Natera Inc. stockExit Point & Weekly Momentum Picks - Newser
What indicators show strength in Natera Inc.2025 Top Gainers & Community Verified Swing Trade Signals - Newser
Can machine learning forecast Natera Inc. recoveryJuly 2025 Action & Free Long-Term Investment Growth Plans - Newser
How does Natera Inc. compare to its peers2025 Trade Ideas & Free Expert Verified Stock Movement Alerts - khodrobank.com
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN
Can Natera Inc. disrupt its industryWeekly Market Outlook & Low Risk High Reward Trade Ideas - khodrobank.com
What is Natera Inc. s revenue forecastQuarterly Profit Review & AI Powered Buy/Sell Recommendations - خودرو بانک
NeoGenomics rallies after court win in Natera patent dispute - MSN
Guidance Update: Should I trade or invest in Natera Inc.Quarterly Trade Review & Comprehensive Market Scan Insights - khodrobank.com
Will Natera Inc. benefit from sector rotationJuly 2025 Highlights & Target Return Focused Picks - خودرو بانک
Risk adjusted return profile for Natera Inc. analyzed2025 Price Action Summary & High Conviction Investment Ideas - Newser
Using flow based indicators on Natera Inc.Trade Risk Assessment & Weekly Stock Performance Updates - Newser
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
0.29%
자본화:
|
볼륨(24시간):